Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	KAT7 KAT6B CREBBP EP300	3.66e-07	15	83	4	GO:0010484
GeneOntologyMolecularFunction	exogenous lipid antigen binding	CD1A CD1B CD1D	6.88e-07	5	83	3	GO:0030884
GeneOntologyMolecularFunction	endogenous lipid antigen binding	CD1A CD1B CD1D	6.88e-07	5	83	3	GO:0030883
GeneOntologyMolecularFunction	lipid antigen binding	CD1A CD1B CD1D	1.37e-06	6	83	3	GO:0030882
GeneOntologyMolecularFunction	N-acyltransferase activity	KAT7 NMT2 KAT6B NMT1 CREBBP EP300	4.21e-06	102	83	6	GO:0016410
GeneOntologyMolecularFunction	lipopeptide binding	CD1A CD1B CD1D	8.14e-06	10	83	3	GO:0071723
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	1.71e-05	2	83	2	GO:0120300
GeneOntologyMolecularFunction	glycylpeptide N-tetradecanoyltransferase activity	NMT2 NMT1	1.71e-05	2	83	2	GO:0004379
GeneOntologyMolecularFunction	peptidyl-lysine N6-myristoyltransferase activity	NMT2 NMT1	1.71e-05	2	83	2	GO:0018030
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	1.71e-05	2	83	2	GO:0044017
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	5.11e-05	3	83	2	GO:0043993
GeneOntologyMolecularFunction	histone acetyltransferase activity	KAT7 KAT6B CREBBP EP300	5.98e-05	51	83	4	GO:0004402
GeneOntologyMolecularFunction	acyltransferase activity, transferring groups other than amino-acyl groups	KAT7 NMT2 KAT6B NMT1 ACSM2A CREBBP EP300	6.02e-05	238	83	7	GO:0016747
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	KAT7 KAT6B CREBBP EP300	8.05e-05	55	83	4	GO:0061733
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	KAT7 KAT6B CREBBP EP300	1.13e-04	60	83	4	GO:0034212
GeneOntologyMolecularFunction	N-acetyltransferase activity	KAT7 KAT6B CREBBP EP300	3.13e-04	78	83	4	GO:0008080
GeneOntologyMolecularFunction	bHLH transcription factor binding	CREBBP EP300 SMAD3	4.86e-04	37	83	3	GO:0043425
GeneOntologyMolecularFunction	histone H3K14 acetyltransferase activity	KAT7 KAT6B	6.03e-04	9	83	2	GO:0036408
GeneOntologyMolecularFunction	medium-chain fatty acid-CoA ligase activity	AACS ACSM2A	9.16e-04	11	83	2	GO:0031956
GeneOntologyMolecularFunction	myristoyltransferase activity	NMT2 NMT1	9.16e-04	11	83	2	GO:0019107
GeneOntologyMolecularFunction	acetyltransferase activity	KAT7 KAT6B CREBBP EP300	9.31e-04	104	83	4	GO:0016407
GeneOntologyMolecularFunction	antigen binding	CD1A CD1B CD1D FCN3 EP300	1.18e-03	190	83	5	GO:0003823
GeneOntologyMolecularFunction	phosphotyrosine residue binding	GRAPL VAV1 GRAP	1.25e-03	51	83	3	GO:0001784
GeneOntologyMolecularFunction	G protein-coupled purinergic nucleotide receptor activity	P2RY6 P2RY11	1.29e-03	13	83	2	GO:0045028
GeneOntologyMolecularFunction	acyltransferase activity	KAT7 RAG2 NMT2 NEURL1 KAT6B NMT1 ACSM2A CREBBP NEURL4 EP300	1.38e-03	775	83	10	GO:0016746
GeneOntologyMolecularFunction	transcription coactivator binding	CREBBP EP300 SMAD3	1.47e-03	54	83	3	GO:0001223
GeneOntologyMolecularFunction	pre-mRNA intronic binding	PRPF8 EP300	1.50e-03	14	83	2	GO:0097157
GeneOntologyMolecularFunction	modification-dependent protein binding	RAG2 TNIP1 PRPF8 EP300 VAV1	1.68e-03	206	83	5	GO:0140030
GeneOntologyMolecularFunction	transmembrane-ephrin receptor activity	EFNA4 EPHA5	1.73e-03	15	83	2	GO:0005005
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	EFNA4 MERTK EPHA5	2.51e-03	65	83	3	GO:0004714
GeneOntologyMolecularFunction	ephrin receptor activity	EFNA4 EPHA5	2.79e-03	19	83	2	GO:0005003
GeneOntologyMolecularFunction	protein phosphorylated amino acid binding	GRAPL VAV1 GRAP	2.98e-03	69	83	3	GO:0045309
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	EP300 SMAD3	3.09e-03	20	83	2	GO:0035259
GeneOntologyMolecularFunction	protein tyrosine kinase activity	TNK1 EFNA4 MERTK EPHA5	3.14e-03	145	83	4	GO:0004713
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	CREBBP EP300	3.41e-03	21	83	2	GO:0042975
GeneOntologyMolecularFunction	nucleotide receptor activity	P2RY6 P2RY11	3.74e-03	22	83	2	GO:0016502
GeneOntologyMolecularFunction	purinergic nucleotide receptor activity	P2RY6 P2RY11	3.74e-03	22	83	2	GO:0001614
GeneOntologyMolecularFunction	histone H4 acetyltransferase activity	KAT7 EP300	4.08e-03	23	83	2	GO:0010485
GeneOntologyMolecularFunction	chromatin DNA binding	H1-9P CREBBP EP300 SMAD3	5.19e-03	167	83	4	GO:0031490
GeneOntologyMolecularFunction	fatty acid ligase activity	AACS ACSM2A	5.20e-03	26	83	2	GO:0015645
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	EFNA4 MERTK EPHA5	5.35e-03	85	83	3	GO:0019199
GeneOntologyMolecularFunction	SMAD binding	CREBBP EP300 SMAD3	5.53e-03	86	83	3	GO:0046332
GeneOntologyMolecularFunction	CoA-ligase activity	AACS ACSM2A	5.60e-03	27	83	2	GO:0016405
GeneOntologyMolecularFunction	peptidase activity	ACR ATG4C PAPPA PRSS58 PRPF8 F2 AGBL1 PCSK9	5.79e-03	654	83	8	GO:0008233
GeneOntologyMolecularFunction	kinase binding	TRIB3 SH2B3 GRAPL TNIP1 ZFYVE26 MYOM2 MVP RHOF EP300 SMAD3	6.79e-03	969	83	10	GO:0019900
GeneOntologyMolecularFunction	acid-thiol ligase activity	AACS ACSM2A	7.34e-03	31	83	2	GO:0016878
GeneOntologyMolecularFunction	serine-type endopeptidase activity	ACR PRSS58 F2 PCSK9	8.14e-03	190	83	4	GO:0004252
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor binding	SACS PCSK9	8.79e-03	34	83	2	GO:0050750
GeneOntologyBiologicalProcess	antigen processing and presentation, endogenous lipid antigen via MHC class Ib	CD1A CD1B CD1D	6.02e-07	5	82	3	GO:0048006
GeneOntologyBiologicalProcess	antigen processing and presentation, exogenous lipid antigen via MHC class Ib	CD1A CD1B CD1D	2.10e-06	7	82	3	GO:0048007
GeneOntologyBiologicalProcess	antigen processing and presentation of lipid antigen via MHC class Ib	CD1A CD1B CD1D	2.10e-06	7	82	3	GO:0048003
GeneOntologyBiologicalProcess	N-terminal protein amino acid modification	NMT2 NMT1 CREBBP EP300	5.11e-06	29	82	4	GO:0031365
GeneOntologyBiologicalProcess	N-terminal peptidyl-glycine N-myristoylation	NMT2 NMT1	1.56e-05	2	82	2	GO:0018008
GeneOntologyBiologicalProcess	peptidyl-glycine modification	NMT2 NMT1	4.67e-05	3	82	2	GO:0018201
GeneOntologyBiologicalProcess	protein acylation	KAT7 NMT2 NMT1 CREBBP EP300	7.10e-05	108	82	5	GO:0043543
GeneOntologyBiologicalProcess	regulation of protein localization to nucleus	KAT7 EPM2A F2 CREBBP EP300 SMAD3	7.26e-05	176	82	6	GO:1900180
GeneOntologyBiologicalProcess	positive regulation of protein localization to nucleus	KAT7 F2 CREBBP EP300 SMAD3	9.18e-05	114	82	5	GO:1900182
GeneOntologyBiologicalProcess	N-terminal protein myristoylation	NMT2 NMT1	9.32e-05	4	82	2	GO:0006499
GeneOntologyBiologicalProcess	protein myristoylation	NMT2 NMT1	9.32e-05	4	82	2	GO:0018377
GeneOntologyBiologicalProcess	N-terminal peptidyl-lysine acetylation	CREBBP EP300	9.32e-05	4	82	2	GO:0018076
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	CD1A CD1B CD1D	1.31e-04	25	82	3	GO:0002475
GeneOntologyBiologicalProcess	peptidyl-lysine acetylation	KAT7 CREBBP EP300	1.85e-04	28	82	3	GO:0018394
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous antigen	CD1A CD1B CD1D	2.76e-04	32	82	3	GO:0019883
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated cytotoxicity	CD1A CD1B CD1D VAV1	2.78e-04	79	82	4	GO:0001912
GeneOntologyBiologicalProcess	N-terminal protein lipidation	NMT2 NMT1	3.24e-04	7	82	2	GO:0006498
GeneOntologyCellularComponent	acetyltransferase complex	KAT7 PDHB KAT6B CREBBP EP300	7.39e-05	109	83	5	GO:1902493
GeneOntologyCellularComponent	H3 histone acetyltransferase complex	KAT7 KAT6B	4.29e-04	8	83	2	GO:0070775
GeneOntologyCellularComponent	histone acetyltransferase complex	KAT7 KAT6B CREBBP EP300	5.37e-04	94	83	4	GO:0000123
GeneOntologyCellularComponent	protein acetyltransferase complex	KAT7 KAT6B CREBBP EP300	7.86e-04	104	83	4	GO:0031248
GeneOntologyCellularComponent	external side of plasma membrane	CD1A CD1B CD1D LCT F2 FCN3 PCSK9 EPHA5	1.06e-03	519	83	8	GO:0009897
HumanPheno	Plantar crease between first and second toes	CREBBP EP300	3.58e-05	2	31	2	HP:0008107
HumanPheno	Aortic isthmus hypoplasia	CREBBP EP300	3.58e-05	2	31	2	HP:0034227
HumanPheno	High axial triradius	CREBBP EP300	3.58e-05	2	31	2	HP:0001042
HumanPheno	Laryngeal cartilage malformation	CREBBP EP300	1.07e-04	3	31	2	HP:0008752
HumanPheno	Phobia	CREBBP EP300	1.07e-04	3	31	2	HP:5200232
HumanPheno	Agoraphobia	CREBBP EP300	1.07e-04	3	31	2	HP:0000756
HumanPheno	Humoral immunodeficiency	CREBBP EP300	1.07e-04	3	31	2	HP:0005363
HumanPheno	Prominent nasal septum	CREBBP EP300	1.07e-04	3	31	2	HP:0005322
HumanPheno	Radial deviation of thumb terminal phalanx	CREBBP EP300	1.07e-04	3	31	2	HP:0005895
HumanPheno	Trichiasis	CREBBP EP300	2.13e-04	4	31	2	HP:0001128
HumanPheno	Visceral hemangioma	CREBBP EP300	2.13e-04	4	31	2	HP:0410266
HumanPheno	Talon cusp	CREBBP EP300	2.13e-04	4	31	2	HP:0011087
HumanPheno	Widened distal phalanges	CREBBP EP300	2.13e-04	4	31	2	HP:0006200
HumanPheno	Vascular ring	CREBBP EP300	2.13e-04	4	31	2	HP:0010775
HumanPheno	Hepatic hemangioma	CREBBP EP300	2.13e-04	4	31	2	HP:0031207
HumanPheno	Abnormality of tear glands or tear production	ELP1 KAT6B GMPPA CREBBP EP300 IGSF3	2.92e-04	156	31	6	HP:0000521
HumanPheno	Papillary cystadenoma of the epididymis	CREBBP EP300	3.54e-04	5	31	2	HP:0009715
HumanPheno	Supernumerary cusp	CREBBP EP300	3.54e-04	5	31	2	HP:0033777
HumanPheno	Epididymal neoplasm	CREBBP EP300	3.54e-04	5	31	2	HP:0030421
Domain	MHC_I_3	CD1A CD1B CD1D	1.56e-06	6	81	3	PF16497
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	1.86e-05	2	81	2	IPR014744
Domain	HAT_KAT11	CREBBP EP300	1.86e-05	2	81	2	PF08214
Domain	KIX	CREBBP EP300	1.86e-05	2	81	2	PS50952
Domain	ZnF_TAZ	CREBBP EP300	1.86e-05	2	81	2	SM00551
Domain	CBP_P300_HAT	CREBBP EP300	1.86e-05	2	81	2	IPR031162
Domain	DUF902	CREBBP EP300	1.86e-05	2	81	2	PF06001
Domain	MyristoylCoA_TrFase_C	NMT2 NMT1	1.86e-05	2	81	2	IPR022677
Domain	MyristoylCoA_TrFase_N	NMT2 NMT1	1.86e-05	2	81	2	IPR022676
Domain	MyristoylCoA_TrFase_CS	NMT2 NMT1	1.86e-05	2	81	2	IPR022678
Domain	-	CREBBP EP300	1.86e-05	2	81	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	1.86e-05	2	81	2	IPR010303
Domain	-	CREBBP EP300	1.86e-05	2	81	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	1.86e-05	2	81	2	PF09030
Domain	NMT_1	NMT2 NMT1	1.86e-05	2	81	2	PS00975
Domain	NMT_2	NMT2 NMT1	1.86e-05	2	81	2	PS00976
Domain	-	CREBBP EP300	1.86e-05	2	81	2	1.10.246.20
Domain	zf-TAZ	CREBBP EP300	1.86e-05	2	81	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	1.86e-05	2	81	2	PS50134
Domain	MyristoylCoA_TrFase	NMT2 NMT1	1.86e-05	2	81	2	IPR000903
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	1.86e-05	2	81	2	IPR013178
Domain	NMT_C	NMT2 NMT1	1.86e-05	2	81	2	PF02799
Domain	NMT	NMT2 NMT1	1.86e-05	2	81	2	PF01233
Domain	KAT11	CREBBP EP300	1.86e-05	2	81	2	SM01250
Domain	Znf_TAZ	CREBBP EP300	1.86e-05	2	81	2	IPR000197
Domain	KIX_dom	CREBBP EP300	1.86e-05	2	81	2	IPR003101
Domain	KIX	CREBBP EP300	1.86e-05	2	81	2	PF02172
Domain	CBP_P300_HAT	CREBBP EP300	1.86e-05	2	81	2	PS51727
Domain	-	KAT7 NMT2 KAT6B NMT1	2.66e-05	40	81	4	3.40.630.30
Domain	Acyl_CoA_acyltransferase	KAT7 NMT2 KAT6B NMT1	4.27e-05	45	81	4	IPR016181
Domain	-	CD1A CD1B CD1D	1.49e-04	24	81	3	3.30.500.10
Domain	MHC_I-like_Ag-recog	CD1A CD1B CD1D	1.49e-04	24	81	3	IPR011161
Domain	NEUZ	NEURL1 NEURL4	1.84e-04	5	81	2	SM00588
Domain	MOZ_SAS	KAT7 KAT6B	1.84e-04	5	81	2	PF01853
Domain	NHR	NEURL1 NEURL4	1.84e-04	5	81	2	PS51065
Domain	HAT_MYST-type	KAT7 KAT6B	1.84e-04	5	81	2	IPR002717
Domain	Neuralized	NEURL1 NEURL4	1.84e-04	5	81	2	PF07177
Domain	NHR_dom	NEURL1 NEURL4	1.84e-04	5	81	2	IPR006573
Domain	MYST_HAT	KAT7 KAT6B	1.84e-04	5	81	2	PS51726
Domain	Nuc_rcpt_coact	CREBBP EP300	2.76e-04	6	81	2	IPR009110
Domain	MHC_I/II-like_Ag-recog	CD1A CD1B CD1D	5.94e-04	38	81	3	IPR011162
Domain	SH2	SH2B3 GRAPL VAV1 GRAP	9.74e-04	101	81	4	PF00017
Domain	SH2	SH2B3 GRAPL VAV1 GRAP	1.34e-03	110	81	4	SM00252
Domain	SH2	SH2B3 GRAPL VAV1 GRAP	1.38e-03	111	81	4	PS50001
Domain	Linker_histone	H1-9P KAT6B	1.40e-03	13	81	2	PF00538
Domain	SH2	SH2B3 GRAPL VAV1 GRAP	1.43e-03	112	81	4	IPR000980
Domain	-	SH2B3 GRAPL VAV1 GRAP	1.43e-03	112	81	4	3.30.505.10
Domain	Histone_H1/H5_H15	H1-9P KAT6B	1.63e-03	14	81	2	IPR005818
Domain	C1-set	CD1A CD1B CD1D	1.66e-03	54	81	3	PF07654
Domain	IGc1	CD1A CD1B CD1D	1.85e-03	56	81	3	SM00407
Domain	Ig_C1-set	CD1A CD1B CD1D	2.04e-03	58	81	3	IPR003597
Domain	SMAD_dom-like	DUSP15 SMAD3	2.14e-03	16	81	2	IPR017855
Domain	-	DUSP15 SMAD3	2.14e-03	16	81	2	2.60.200.10
Domain	ZZ	CREBBP EP300	2.72e-03	18	81	2	PF00569
Domain	ZF_ZZ_2	CREBBP EP300	2.72e-03	18	81	2	PS50135
Domain	ZF_ZZ_1	CREBBP EP300	2.72e-03	18	81	2	PS01357
Domain	Znf_ZZ	CREBBP EP300	3.03e-03	19	81	2	IPR000433
Domain	ZnF_ZZ	CREBBP EP300	3.03e-03	19	81	2	SM00291
Domain	Znf_FYVE_PHD	RAG2 PHF14 ZFYVE26 KAT6B	3.83e-03	147	81	4	IPR011011
Domain	Cupredoxin	EFNA4 PRPF8	4.06e-03	22	81	2	IPR008972
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR	ARNT CREBBP EP300	1.12e-05	11	59	3	M26924
Pathway	REACTOME_SIGNALING_BY_SCF_KIT	SH2B3 GRAPL VAV1 GRAP	1.65e-05	37	59	4	MM14564
Pathway	BIOCARTA_TGFB_PATHWAY	CREBBP EP300 SMAD3	4.54e-05	17	59	3	MM1509
Pathway	BIOCARTA_TGFB_PATHWAY	CREBBP EP300 SMAD3	6.43e-05	19	59	3	M18933
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	CREBBP EP300 SMAD3	7.55e-05	20	59	3	M27881
Pathway	BIOCARTA_NTHI_PATHWAY	CREBBP EP300 SMAD3	1.01e-04	22	59	3	MM1443
Pathway	BIOCARTA_NTHI_PATHWAY	CREBBP EP300 SMAD3	1.16e-04	23	59	3	M2821
Pathway	PID_HIF1_TFPATHWAY	ARNT CREBBP EP300 SMAD3	1.64e-04	66	59	4	M255
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	1.71e-04	5	59	2	MM1575
Pathway	REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES	CREBBP EP300	1.71e-04	5	59	2	M48020
Pathway	REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES	CREBBP EP300	1.71e-04	5	59	2	M48023
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	CREBBP EP300	1.71e-04	5	59	2	M27228
Pathway	WP_KIT_RECEPTOR_SIGNALING_PATHWAY	GRAPL EP300 VAV1 GRAP	2.18e-04	71	59	4	MM15947
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	2.56e-04	6	59	2	M22062
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR	ARNT EP300	2.56e-04	6	59	2	MM14521
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	KAT7 ELP1 KAT6B CREBBP EP300	3.13e-04	142	59	5	M27233
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	3.57e-04	7	59	2	MM1573
Pathway	KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN	PIK3R4 EPM2A	3.57e-04	7	59	2	M47977
Pathway	WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA	ARNT CREBBP EP300	3.80e-04	34	59	3	M39771
Pathway	KEGG_BUTANOATE_METABOLISM	PDHB AACS ACSM2A	3.80e-04	34	59	3	M3397
Pathway	PID_HIF2PATHWAY	ARNT CREBBP EP300	3.80e-04	34	59	3	M44
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	4.74e-04	8	59	2	M22058
Pathway	REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES	CREBBP EP300	4.74e-04	8	59	2	M48022
Pathway	REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION	CREBBP EP300	4.74e-04	8	59	2	M48024
Pathway	KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN	F2 FCN3	4.74e-04	8	59	2	M47784
Pathway	REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES	CREBBP EP300	4.74e-04	8	59	2	M46443
Pathway	WP_ANDROGEN_RECEPTOR_SIGNALING	KAT7 CREBBP EP300 SMAD3	5.64e-04	91	59	4	M39700
Pathway	KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY	CREBBP EP300	6.08e-04	9	59	2	M47451
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	CREBBP EP300	7.58e-04	10	59	2	M27945
Pathway	REACTOME_SIGNALING_BY_SCF_KIT	SH2B3 VAV1 GRAP	7.63e-04	43	59	3	M508
Pathway	BIOCARTA_CARM1_PATHWAY	CREBBP EP300	9.24e-04	11	59	2	MM1521
Pathway	REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES	CREBBP EP300	9.24e-04	11	59	2	M48021
Pathway	PID_HES_HEY_PATHWAY	ARNT CREBBP EP300	1.05e-03	48	59	3	M288
Pathway	BIOCARTA_CARM1_PATHWAY	CREBBP EP300	1.11e-03	12	59	2	M7968
Pathway	REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS	CREBBP EP300	1.11e-03	12	59	2	M27765
Pathway	REACTOME_P2Y_RECEPTORS	P2RY6 P2RY11	1.11e-03	12	59	2	M10960
Pathway	REACTOME_SIGNALING_BY_NOTCH3	NEURL1 CREBBP EP300	1.12e-03	49	59	3	M618
Pathway	PID_KIT_PATHWAY	SH2B3 CREBBP VAV1	1.33e-03	52	59	3	M231
Pathway	PID_NFAT_3PATHWAY	CABIN1 CREBBP EP300	1.41e-03	53	59	3	M113
Pathway	PID_AR_TF_PATHWAY	KAT7 CREBBP EP300	1.41e-03	53	59	3	M151
Pathway	WP_TGFBETA_SIGNALING_PATHWAY	CREBBP EP300 SMAD3	1.41e-03	53	59	3	MM15880
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	ARNT TRIB3 CREBBP EP300	1.49e-03	118	59	4	M27316
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	CREBBP EP300	1.52e-03	14	59	2	M27808
Pathway	WP_TGFBETA_RECEPTOR_SIGNALING	CREBBP EP300 SMAD3	1.57e-03	55	59	3	M39351
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	PIK3R4 TRIB3 SH2B3 GRAPL EP300 VAV1 GRAP	1.73e-03	418	59	7	MM15587
Pathway	BIOCARTA_RELA_PATHWAY	CREBBP EP300	1.75e-03	15	59	2	MM1339
Pathway	BIOCARTA_HIF_PATHWAY	ARNT EP300	1.75e-03	15	59	2	M13324
Pathway	BIOCARTA_RELA_PATHWAY	CREBBP EP300	1.75e-03	15	59	2	M10183
Pathway	BIOCARTA_PITX2_PATHWAY	CREBBP EP300	1.75e-03	15	59	2	MM1439
Pathway	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	CREBBP EP300	1.75e-03	15	59	2	M953
Pathway	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	NEURL1 CREBBP EP300	1.82e-03	58	59	3	M29616
Pathway	WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS	CREBBP EP300 SMAD3	1.92e-03	59	59	3	M39886
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	CREBBP EP300	1.99e-03	16	59	2	M27121
Pathway	BIOCARTA_MEF2D_PATHWAY	CABIN1 EP300	1.99e-03	16	59	2	MM1483
Pathway	BIOCARTA_IL7_PATHWAY	CREBBP EP300	1.99e-03	16	59	2	M1296
Pathway	BIOCARTA_IL7_PATHWAY	CREBBP EP300	1.99e-03	16	59	2	MM1420
Pathway	REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS	P2RY6 P2RY11	1.99e-03	16	59	2	M6786
Pathway	BIOCARTA_PITX2_PATHWAY	CREBBP EP300	1.99e-03	16	59	2	M8516
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	CREBBP EP300	1.99e-03	16	59	2	M27940
Pathway	REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS	EP300 SMAD3	1.99e-03	16	59	2	M46428
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	CREBBP EP300	2.25e-03	17	59	2	M48025
Pathway	BIOCARTA_MEF2D_PATHWAY	CABIN1 EP300	2.52e-03	18	59	2	M5290
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	CREBBP EP300	2.52e-03	18	59	2	M26942
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION	CREBBP EP300 SMAD3	2.64e-03	66	59	3	M27938
Pathway	REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES	CREBBP EP300	2.81e-03	19	59	2	M46442
Pathway	WP_UROTENSINIIMEDIATED_SIGNALING	CREBBP EP300 SMAD3	3.00e-03	69	59	3	M48052
Pathway	WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS	CABIN1 EP300	3.12e-03	20	59	2	M48330
Pathway	KEGG_RENAL_CELL_CARCINOMA	ARNT CREBBP EP300	3.12e-03	70	59	3	M13266
Pathway	WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX	CREBBP EP300	3.44e-03	21	59	2	M39593
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	CREBBP EP300	3.44e-03	21	59	2	M27485
Pathway	KEGG_ADHERENS_JUNCTION	CREBBP EP300 SMAD3	3.52e-03	73	59	3	M638
Pathway	REACTOME_SIGNALING_BY_NOTCH1	NEURL1 CREBBP EP300	3.66e-03	74	59	3	M616
Pathway	BIOCARTA_VDR_PATHWAY	CREBBP EP300	3.77e-03	22	59	2	MM1370
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION	EP300 SMAD3	3.77e-03	22	59	2	MM15656
Pathway	REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES	ARNT CREBBP	3.77e-03	22	59	2	M46437
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA	ARNT CREBBP EP300	3.80e-03	75	59	3	M641
Pubmed	Antigen presentation by CD1 and MHC-encoded class I-like molecules.	CD1A CD1B CD1D	5.43e-08	4	84	3	8729450
Pubmed	Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them.	CD1A CD1B CD1D	5.43e-08	4	84	3	24556395
Pubmed	CD1-dependent dendritic cell instruction.	CD1A CD1B CD1D	5.43e-08	4	84	3	12415264
Pubmed	Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment.	CREBBP EP300 SMAD3	1.35e-07	5	84	3	15623506
Pubmed	Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens.	CD1A CD1B CD1D	1.35e-07	5	84	3	3097645
Pubmed	TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300.	CREBBP EP300 SMAD3	1.35e-07	5	84	3	9679056
Pubmed	Polymorphism of human CD1 genes.	CD1A CD1B CD1D	1.35e-07	5	84	3	10488738
Pubmed	Dynamics of the antigen-binding grooves in CD1 proteins: reversible hydrophobic collapse in the lipid-free state.	CD1A CD1B CD1D	1.35e-07	5	84	3	23677998
Pubmed	CD1: antigen presentation and T cell function.	CD1A CD1B CD1D	1.35e-07	5	84	3	15032598
Pubmed	E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins.	CREBBP EP300 SMAD3	1.35e-07	5	84	3	10497242
Pubmed	Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.	KAT7 KAT6B EP300	1.35e-07	5	84	3	17182677
Pubmed	IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa.	CD1A CD1B CD1D	1.35e-07	5	84	3	18337560
Pubmed	Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins.	CREBBP EP300 SMAD3	1.35e-07	5	84	3	12743039
Pubmed	A physical map linking the five CD1 human thymocyte differentiation antigen genes.	CD1A CD1B CD1D	1.35e-07	5	84	3	2583117
Pubmed	CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease.	CD1A CD1B CD1D	1.35e-07	5	84	3	11580851
Pubmed	Role of CBP in regulating HIF-1-mediated activation of transcription.	ARNT CREBBP EP300	2.70e-07	6	84	3	15615775
Pubmed	Pokemon (FBI-1) interacts with Smad4 to repress TGF-β-induced transcriptional responses.	CREBBP EP300 SMAD3	4.72e-07	7	84	3	25514493
Pubmed	Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).	CREBBP EP300 SMAD3	7.54e-07	8	84	3	14691252
Pubmed	Acetylation of HIV-1 integrase by p300 regulates viral integration.	KAT7 KAT6B EP300	2.21e-06	11	84	3	16096645
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	5.76e-06	2	84	2	27881875
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	5.76e-06	2	84	2	34845315
Pubmed	Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding.	NMT2 NMT1	5.76e-06	2	84	2	12244217
Pubmed	p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts.	CREBBP EP300	5.76e-06	2	84	2	19729597
Pubmed	CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.	RAG2 CD1D	5.76e-06	2	84	2	12042809
Pubmed	Thymus-Derived CD4+CD8+ Cells Reside in Mediastinal Adipose Tissue and the Aortic Arch.	RAG2 CD1D	5.76e-06	2	84	2	34740961
Pubmed	Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling.	GRAPL GRAP	5.76e-06	2	84	2	19836472
Pubmed	Dynamic changes in chromatin acetylation and the expression of histone acetyltransferases and histone deacetylases regulate the SM22alpha transcription in response to Smad3-mediated TGFbeta1 signaling.	EP300 SMAD3	5.76e-06	2	84	2	16876108
Pubmed	CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.	CREBBP EP300	5.76e-06	2	84	2	39287984
Pubmed	Anatomy of CD1-lipid antigen complexes.	CD1A CD1B	5.76e-06	2	84	2	15864273
Pubmed	Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.	NMT2 NMT1	5.76e-06	2	84	2	9971769
Pubmed	Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction.	GRAPL GRAP	5.76e-06	2	84	2	11971956
Pubmed	Antimyristoylation of the gag proteins in the human immunodeficiency virus-infected cells with N-myristoyl glycinal diethylacetal resulted in inhibition of virus production.	NMT2 NMT1	5.76e-06	2	84	2	2692561
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	5.76e-06	2	84	2	20717166
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	5.76e-06	2	84	2	25893291
Pubmed	Chemical characterization of p17gag from human immunodeficiency virus as an N-terminally myristoylated protein.	NMT2 NMT1	5.76e-06	2	84	2	2737204
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	5.76e-06	2	84	2	11559821
Pubmed	CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.	CREBBP EP300	5.76e-06	2	84	2	32576962
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	5.76e-06	2	84	2	19822209
Pubmed	Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.	NMT2 NMT1	5.76e-06	2	84	2	19403686
Pubmed	A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis.	CREBBP EP300	5.76e-06	2	84	2	24522976
Pubmed	Automated fluorescence lifetime imaging plate reader and its application to Förster resonant energy transfer readout of Gag protein aggregation.	NMT2 NMT1	5.76e-06	2	84	2	23184449
Pubmed	CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.	CREBBP EP300	5.76e-06	2	84	2	21847097
Pubmed	Entropic switch regulates myristate exposure in the HIV-1 matrix protein.	NMT2 NMT1	5.76e-06	2	84	2	14699046
Pubmed	Global profiling of co- and post-translationally N-myristoylated proteomes in human cells.	NMT2 NMT1	5.76e-06	2	84	2	25255805
Pubmed	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.	CREBBP EP300	5.76e-06	2	84	2	34813504
Pubmed	Rubinstein-Taybi Syndrome	CREBBP EP300	5.76e-06	2	84	2	20301699
Pubmed	Immunosuppression and Aberrant T Cell Development in the Absence of N-Myristoylation.	NMT2 NMT1	5.76e-06	2	84	2	26423150
Pubmed	Potential biomarker of metformin action.	CREBBP EP300	5.76e-06	2	84	2	24639469
Pubmed	The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels.	CREBBP EP300	5.76e-06	2	84	2	37816914
Pubmed	Binding of p300/CBP co-activators by polyoma large T antigen.	CREBBP EP300	5.76e-06	2	84	2	11438528
Pubmed	Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.	CREBBP EP300	5.76e-06	2	84	2	10918613
Pubmed	Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.	CREBBP EP300	5.76e-06	2	84	2	35502657
Pubmed	Nef protein of human immunodeficiency virus type 1 binds its own myristoylated N-terminus.	NMT2 NMT1	5.76e-06	2	84	2	17261081
Pubmed	p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.	CREBBP EP300	5.76e-06	2	84	2	31898871
Pubmed	Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.	CREBBP EP300	5.76e-06	2	84	2	30888860
Pubmed	Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly.	NMT2 NMT1	5.76e-06	2	84	2	2194551
Pubmed	Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.	CREBBP EP300	5.76e-06	2	84	2	27881443
Pubmed	Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.	NMT2 NMT1	5.76e-06	2	84	2	10074105
Pubmed	Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts.	CREBBP EP300	5.76e-06	2	84	2	19272189
Pubmed	Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein.	NMT2 NMT1	5.76e-06	2	84	2	10339411
Pubmed	Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.	NMT2 NMT1	5.76e-06	2	84	2	9261380
Pubmed	Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.	CREBBP EP300	5.76e-06	2	84	2	32690000
Pubmed	CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.	CREBBP EP300	5.76e-06	2	84	2	30953353
Pubmed	Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.	CREBBP EP300	5.76e-06	2	84	2	21803292
Pubmed	Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.	NMT2 NMT1	5.76e-06	2	84	2	8970978
Pubmed	N-myristoyltransferase 1 is essential in early mouse development.	NMT2 NMT1	5.76e-06	2	84	2	15753093
Pubmed	HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.	CREBBP EP300	5.76e-06	2	84	2	9811832
Pubmed	Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.	CREBBP EP300	5.76e-06	2	84	2	24089570
Pubmed	Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer.	RAG2 SMAD3	5.76e-06	2	84	2	19119184
Pubmed	Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.	CREBBP EP300	5.76e-06	2	84	2	15706485
Pubmed	Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.	NMT2 NMT1	5.76e-06	2	84	2	10196310
Pubmed	AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.	CREBBP EP300	5.76e-06	2	84	2	39266679
Pubmed	A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.	CREBBP EP300	5.76e-06	2	84	2	22303793
Pubmed	Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.	CREBBP EP300	5.76e-06	2	84	2	34732714
Pubmed	An SH2 domain-dependent, phosphotyrosine-independent interaction between Vav1 and the Mer receptor tyrosine kinase: a mechanism for localizing guanine nucleotide-exchange factor action.	MERTK VAV1	5.76e-06	2	84	2	12920122
Pubmed	Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.	CREBBP EP300	5.76e-06	2	84	2	34019788
Pubmed	Detection of Grb-2-related adaptor protein gene (GRAP) and peptide molecule in salivary glands of MRL/lpr mice and patients with Sjögren's syndrome.	GRAPL GRAP	5.76e-06	2	84	2	15174222
Pubmed	Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.	CREBBP EP300	5.76e-06	2	84	2	15860545
Pubmed	Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.	CREBBP EP300	5.76e-06	2	84	2	29460469
Pubmed	Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.	CREBBP EP300	5.76e-06	2	84	2	24551300
Pubmed	Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.	NMT2 NMT1	5.76e-06	2	84	2	2405382
Pubmed	Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells.	NMT2 NMT1	5.76e-06	2	84	2	16306631
Pubmed	The biology and enzymology of protein N-myristoylation.	NMT2 NMT1	5.76e-06	2	84	2	11527981
Pubmed	Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.	CREBBP EP300	5.76e-06	2	84	2	33911074
Pubmed	The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.	CREBBP EP300	5.76e-06	2	84	2	9018065
Pubmed	Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure.	CREBBP EP300	5.76e-06	2	84	2	24648406
Pubmed	CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity.	CREBBP EP300	5.76e-06	2	84	2	30135524
Pubmed	Distribution of co-activators CBP and p300 during mouse oocyte and embryo development.	CREBBP EP300	5.76e-06	2	84	2	16596650
Pubmed	CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.	CSMD1 SMAD3	5.76e-06	2	84	2	22538441
Pubmed	The effect of HIV-1 Gag myristoylation on membrane binding.	NMT2 NMT1	5.76e-06	2	84	2	16183191
Pubmed	A second mammalian N-myristoyltransferase.	NMT2 NMT1	5.76e-06	2	84	2	9506952
Pubmed	The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.	CREBBP EP300	5.76e-06	2	84	2	29217654
Pubmed	Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.	CREBBP EP300	5.76e-06	2	84	2	10049825
Pubmed	CBP/p300 acetyltransferase activity in hematologic malignancies.	CREBBP EP300	5.76e-06	2	84	2	27380996
Pubmed	CREBBP and p300 lysine acetyl transferases in the DNA damage response.	CREBBP EP300	5.76e-06	2	84	2	29170789
Pubmed	Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.	CREBBP EP300	5.76e-06	2	84	2	21555743
Pubmed	CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells.	CREBBP EP300	5.76e-06	2	84	2	12646247
Pubmed	Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.	NMT2 NMT1	5.76e-06	2	84	2	7521919
Pubmed	Blockage of N-myristoylation of HIV-1 gag induces the production of impotent progeny virus.	NMT2 NMT1	5.76e-06	2	84	2	9299393
Pubmed	Grb2-related adaptor protein GRAP is a novel regulator of liver fibrosis.	GRAPL GRAP	5.76e-06	2	84	2	37343720
Interaction	NR6A1 interactions	ARNT EFNA4 CREBBP EP300	2.54e-06	24	82	4	int:NR6A1
Interaction	DPM1 interactions	ARNT P2RY6 TNIP1 MERTK PRPF8 RHOF EP300	6.73e-06	173	82	7	int:DPM1
Interaction	PRKDC interactions	ARNT EFNA4 MEX3A P2RY6 ELP1 ATG4C TNIP1 MERTK PRPF8 RHOF EP300 SMAD3	2.34e-05	695	82	12	int:PRKDC
Interaction	CIMAP1D interactions	NMT2 NMT1 TRAPPC9	2.85e-05	15	82	3	int:CIMAP1D
Interaction	KAT6A interactions	KAT7 MEX3A AP3B2 PHF14 KAT6B PRPF8 CREBBP EP300 TOE1 SMAD3	4.13e-05	510	82	10	int:KAT6A
Interaction	SAXO1 interactions	TNK1 TRIB3 FAM124A MVP	5.08e-05	50	82	4	int:SAXO1
Cytoband	1q22-q23	CD1A CD1B CD1D	1.67e-06	13	84	3	1q22-q23
Cytoband	3q25.32	RARRES1 IQCJ	1.80e-04	11	84	2	3q25.32
Cytoband	9q33.2	TTLL11 PAPPA	2.35e-03	39	84	2	9q33.2
Cytoband	10p13	FRMD4A NMT2	2.85e-03	43	84	2	10p13
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT7 KAT6B CREBBP EP300	1.64e-07	17	54	4	486
GeneFamily	SH2 domain containing	SH2B3 GRAPL VAV1 GRAP	2.34e-04	101	54	4	741
GeneFamily	C1-set domain containing	CD1A CD1B CD1D	2.66e-04	42	54	3	591
GeneFamily	Purinergic receptors P2Y	P2RY6 P2RY11	3.88e-04	10	54	2	213
GeneFamily	Zinc fingers C2HC-type\|PHD finger proteins\|Lysine acetyltransferases	KAT7 KAT6B	1.02e-03	16	54	2	66
GeneFamily	Atypical dual specificity phosphatases	EPM2A DUSP15	1.30e-03	18	54	2	896
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	1.30e-03	18	54	2	91
GeneFamily	Acyl-CoA synthetase family	AACS ACSM2A	2.72e-03	26	54	2	40
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Calb2_(MGE-derived_cortical_interneurons--Martinotti_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TMEM267 IQCJ PAPPA MAMDC4	1.06e-05	73	83	4	8e8d06bd4404fe6fda753e7adedc2f2150524750
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Calb2_(MGE-derived_cortical_interneurons--Martinotti_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TMEM267 IQCJ PAPPA MAMDC4	1.06e-05	73	83	4	48a499fa03d736310d09b01c8889db5288e9b2da
ToppCell	droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTSL5 BIVM NEURL4 RHOF VAV1	1.48e-05	166	83	5	35db3022c33d6f8bb6587d9eec89a7cccb70271a
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2R1 RARRES1 ADAMTSL5 SACS MYOM2	1.76e-05	172	83	5	073a503dc922e3e3ac3528e249b0f8b74402110b
ToppCell	Dendritic_Cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	CD1A CD1B CD1D P2RY6 CDCP2	1.91e-05	175	83	5	584290a51f9975782a5ac8c6ad67c778d8323f8c
ToppCell	droplet-Heart-nan-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEX3A PAPPA DUSP15 CSMD1 NEURL4	2.76e-05	189	83	5	0493f7b79127c207fd7ade778ef4810500495d7e
ToppCell	(3)_MNP-(3)_DC_2\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	CD1A CD1B CD1D P2RY6 RHOF	2.90e-05	191	83	5	3ff163484af8c12ef4eef87246cf044257fd2547
ToppCell	COVID-19-Myeloid-DC2\|Myeloid / Condition, Lineage and Cell class	CD1A CD1B CD1D P2RY6 RHOF	3.05e-05	193	83	5	5f3f6db3d3de887d004662d229f42549601efa81
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD1A CD1B P2RY6 CH25H RHOF	3.13e-05	194	83	5	e56c6e5c9b7d287ae94566b561e21cec2055f83d
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_2-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1A CD1B CD1D SACS P2RY6	3.21e-05	195	83	5	7606b8b40e704bb5447ac57ccf8698794e9c7890
ToppCell	356C-Myeloid-Dendritic-cDC2\|356C / Donor, Lineage, Cell class and subclass (all cells)	CD1A CD1B CD1D P2RY6 CH25H	3.21e-05	195	83	5	4c9a2167d8cfe40dfd609c303ada5b5ef800bd8f
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD1A CD1B P2RY6 CH25H RHOF	3.21e-05	195	83	5	85fee07d71c0393ea42bcf1130566dff4a62f507
ToppCell	Leuk-UTI-Myeloid-cDC2\|Leuk-UTI / Disease, Lineage and Cell Type	CD1B CD1D P2RY6 PDHB ATG4C	3.29e-05	196	83	5	50465a082f03201936733c55af73bc32e1bdd024
ToppCell	Control-Myeloid-DC2\|Control / Condition, Lineage and Cell class	CD1A CD1B P2RY6 CH25H RHOF	3.29e-05	196	83	5	0ccc26c2811e4c8631e0abd8555b167ac1e7a982
ToppCell	Transplant_Alveoli_and_parenchyma-Immune-Dendritic_cells\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	CD1A CD1B CD1D P2RY6 RHOF	3.29e-05	196	83	5	f278b144b8deaee0bf41682081b9fbb0b1e82b19
ToppCell	Control-Myeloid-DC2\|Myeloid / Condition, Lineage and Cell class	CD1A CD1B P2RY6 CH25H RHOF	3.37e-05	197	83	5	e0ee15188ff0d9df3c3b5ea523553ce18d223c33
ToppCell	proximal-3-Hematologic-Myeloid_Dendritic_Type_2\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1A CD1B CD1D SH2B3 P2RY6	3.45e-05	198	83	5	2e07e62ed230763a6859a8ce19429b5ca8b365a6
ToppCell	proximal-Hematologic-Myeloid_Dendritic_Type_2\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1A CD1B CD1D SH2B3 P2RY6	3.45e-05	198	83	5	3b0143efc33486c1e340ca57981c83cf7e2cad29
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CD1A SH2B3 P2RY6 MERTK ARAP1	3.45e-05	198	83	5	0b928a829844f49f4d47e88908af192cb919011f
ToppCell	proximal-Hematologic-Myeloid_Dendritic_Type_2-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1A CD1B CD1D SH2B3 P2RY6	3.45e-05	198	83	5	f254287e13328a8f3b14bf4e44736041ad35593e
ToppCell	normal_Lung-Myeloid_cells-CD1c+_DCs\|normal_Lung / Location, Cell class and cell subclass	CD1A CD1B CD1D SH2B3 P2RY6	3.45e-05	198	83	5	85d9bf50a1a5adaab52bab88317acd870d1704d6
ToppCell	tumor_Lung-Myeloid_cells-CD1c+_DCs\|tumor_Lung / Location, Cell class and cell subclass	CD1A CD1B CD1D SH2B3 P2RY6	3.53e-05	199	83	5	de65f2f41a507ae98d27c37aedac7fdbf2d3c697
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CD1D SH2B3 P2RY6 MERTK VAV1	3.53e-05	199	83	5	6ce7612ee2ae211eb0f73391e96089ad5431c537
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FRMD4A SH2B3 NEURL4 TOE1 RAVER1	3.62e-05	200	83	5	88d713dfc792e7609bf7ecfb28f87cb748088570
ToppCell	Transverse-Dendritic_cell\|Transverse / Region, Cell class and subclass	CD1A CD1B CD1D SH2B3 P2RY6	3.62e-05	200	83	5	b0e9eaf0e57e53645e272e2cea9f09bfcfe12a9b
ToppCell	Transverse-(5)_Dendritic_cell\|Transverse / shred on region, Cell_type, and subtype	CD1A CD1B CD1D SH2B3 P2RY6	3.62e-05	200	83	5	6c32a64f7c38818b93eec1e2d41067e5dbd90541
ToppCell	Sepsis-Leuk-UTI-Myeloid-cDC2\|Leuk-UTI / Disease, condition lineage and cell class	CD1B CD1D P2RY6 PDHB ATG4C	3.62e-05	200	83	5	1f1611c590230cd50b9bdca6b58291ab3aab85f2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	PLA2R1 EFNA4 P2RY6 P2RY11 MERTK	3.62e-05	200	83	5	be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOXRED1 SACS P2RY6 TTLL11	1.36e-04	140	83	4	276b3fa924176426efb31112ed4d355407f0b218
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD1B CD1D SH2B3 P2RY6	2.12e-04	157	83	4	e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPM2A NEURL1 CSMD1 F2	2.12e-04	157	83	4	1f21d78a467fe22c5ab75d0917b840c1ac93f32c
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD1B CD1D SH2B3 P2RY6	2.17e-04	158	83	4	e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5\|TCGA-Stomach / Sample_Type by Project: Shred V9	MEX3A PROCA1 DUSP15 F2	2.22e-04	159	83	4	c40fe552da3abdb1df87e9e1647468dc038bec0a
ToppCell	normal_Lung-Myeloid_cells-Pleural_Mac\|normal_Lung / Location, Cell class and cell subclass	CD1A CD1B CD1D P2RY6	2.22e-04	159	83	4	f95a5570bf153fc5c598aba855db6b47ba818463
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RAG2 CD1A CD1B LCT	2.39e-04	162	83	4	a27750117e7f16a0bd07cc5f58a56becb39e800b
ToppCell	tumor_Lung-Myeloid_cells-Pleural_Mac\|tumor_Lung / Location, Cell class and cell subclass	CD1A CD1B CD1D P2RY6	2.39e-04	162	83	4	9ac3242511315224ed94582aca9e9a3786cd01a0
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD1B CD1D EPM2A CH25H	2.44e-04	163	83	4	ec8336b68c8369e27d507c04c827be07bb48a7f6
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD1A CD1B CD1D SACS	2.68e-04	167	83	4	1bd0aa7a3c8649f342bb856cf861c4c5984ad889
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	PIK3R4 PLA2R1 TRIB3 MYOM2	2.68e-04	167	83	4	e488d9c7cf4355959e3833de3bd496c13fc11b1b
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	EML5 P2RY11 ZFYVE26 DENND4C	2.68e-04	167	83	4	a48349f189f6a8d563744b0a294c3974f3a18f50
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2R1 ADAMTSL5 MYOM2 MERTK	2.80e-04	169	83	4	87116c33c5ca8cb1862e103e5607b1df4d264569
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD1B CD1D SH2B3 P2RY6	2.87e-04	170	83	4	7bba77ae34a0259fad6ee98cf665ff50f77a1328
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD1B CD1D SH2B3 P2RY6	2.87e-04	170	83	4	a43b977a7fe745536cf96b7c080397d9fa73086b
ToppCell	TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4\|TCGA-Adrenal / Sample_Type by Project: Shred V9	EFNA4 AACS IDH1 RHOF	3.13e-04	174	83	4	15e2b9f46404ff9575e149024b24cb17b50b02b5
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAG2 EFNA4 ACR TTLL11	3.27e-04	176	83	4	3766e0533b103ec92ac75eba3df02e287efc53fa
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAG2 EFNA4 ACR TTLL11	3.27e-04	176	83	4	aa1bada2175d8370fc71939a607407155259d195
ToppCell	10x3'2.3-week_17-19-Myeloid_DC-DC-DC3\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CD1A CD1B CD1D P2RY6	3.27e-04	176	83	4	7762e5d7c11756da605a604a289216bb53e25869
ToppCell	NS-moderate-d_0-4-Myeloid-pDC\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	STARD4 SH2B3 P2RY6 RHOF	3.34e-04	177	83	4	de1ffe3df76100d46ca158bdd2fea2ebbd4656b4
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	FRMD4A INTU P2RY6 MERTK	3.56e-04	180	83	4	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAG2 TTLL11 DUSP15 MYOM2	3.63e-04	181	83	4	145fae2746c5212640b7b11b04a7759ba8e5c322
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAG2 TTLL11 DUSP15 MYOM2	3.63e-04	181	83	4	a9f1fc5973cffdbeb7d1f5c41534422d85d596ff
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TTLL11 MYOM2 KAT6B TRAPPC9	3.71e-04	182	83	4	c6172aca2475bf0948a78e39f0dae6388504a915
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FRMD4A CD1B P2RY6 MERTK	3.71e-04	182	83	4	ea39b1b5db185b0cb11dfa2e01f3f972effbd770
ToppCell	10x5'v1-week_17-19-Myeloid_DC-DC-tDC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	EML5 P2RY6 MVP RHOF	3.71e-04	182	83	4	ad5c99ec62cdab347d3a03c971d981e3b924020c
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD1c+_DCs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	CD1A CD1B CD1D SH2B3	3.71e-04	182	83	4	551d301adfb4d5046c5f60f6996450621b04e9b2
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTSL5 PAPPA FAM124A LCT	3.79e-04	183	83	4	ebe369dc80c4fbf8f4dbe947147f8c47507ffb60
ToppCell	mild-Myeloid-mDC\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CD1B CD1D SH2B3 P2RY6	3.87e-04	184	83	4	8b37c00d59d9992d3b43268991da7bb94646c70e
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	CD1A CD1B SH2B3 P2RY6	3.87e-04	184	83	4	2dc4b2a9970111ed5e2977fc178595a12d7bb59d
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2R1 RARRES1 ADAMTSL5 MYOM2	3.87e-04	184	83	4	1c857126c0ea0671f0d60b048efca288d348d653
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175\|Adult / Lineage, Cell type, age group and donor	FRMD4A P2RY6 MERTK VAV1	3.95e-04	185	83	4	ab5704b96f1d368911308797d10c7c52766ab134
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FRMD4A P2RY6 ATG4C MERTK	3.95e-04	185	83	4	8207f9eff113eed429e961748c6b17d672a13b33
ToppCell	10x5'-GI_small-bowel-Myeloid_Dendritic-DC2\|GI_small-bowel / Manually curated celltypes from each tissue	CD1A CD1B CD1D P2RY6	3.95e-04	185	83	4	f78be85dd6e443abb7af20f98ff351c1131ece4d
ToppCell	(0)_MSCs\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	CD1D PAPPA CSMD1 IGSF3	4.03e-04	186	83	4	a832c1e0035bcd559722eccf262c145deb3494c7
ToppCell	(0)_MSCs-(00)_Lepr-MSC\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	CD1D PAPPA CSMD1 IGSF3	4.03e-04	186	83	4	f0d156167d7cc2cd8a76e5a364233e9f2170bc01
ToppCell	COVID_non-vent-Myeloid-Dendritic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CD1B CD1D SH2B3 P2RY6	4.11e-04	187	83	4	936aaca144b79a809617cbe3058bf434a4b3d46a
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SH2B3 P2RY6 ATG4C MERTK	4.11e-04	187	83	4	39b99f46b723f7f3c44880d7fe8642cbad558b8a
ToppCell	COVID_non-vent-Myeloid-Dendritic-cDC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CD1B CD1D SH2B3 P2RY6	4.11e-04	187	83	4	55fe4e8b4f301876716c1af15c34d42164f2358e
ToppCell	3'_v3-Lung-Myeloid_Dendritic-DC2\|Lung / Manually curated celltypes from each tissue	CD1A CD1B CD1D P2RY6	4.36e-04	190	83	4	468525c05e38158a3b8a445882b2d63dfb1d2c63
ToppCell	COVID-19-Myeloid-DC2\|COVID-19 / Condition, Lineage and Cell class	CD1A CD1B CD1D P2RY6	4.45e-04	191	83	4	1304ab7b5713f29f3966ffc020ea1b52e8e2f375
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	FRMD4A CD1D PAPPA IGSF3	4.45e-04	191	83	4	78ad7c555409ce1391bce406bc0f3ef575329ece
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD1B CD1D SH2B3 P2RY6	4.45e-04	191	83	4	92c5a26b90a55831039220341d863cf2940f3c9b
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD1B CD1D SH2B3 P2RY6	4.54e-04	192	83	4	6184163dbfca882824cb266bb9030d9f79e3acb0
ToppCell	367C-Myeloid-Dendritic\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CD1A CD1B P2RY6 RHOF	4.54e-04	192	83	4	877aaf61d8fc40e7013944a0180306dd0bb0557f
ToppCell	367C-Myeloid-Dendritic-cDC2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CD1A CD1B CD1D RHOF	4.63e-04	193	83	4	940e9a419d0de1f9e72b5cc9c86684057003be58
ToppCell	MNPs-Dendritic_Cells\|MNPs / lung cells shred on cell class, cell subclass, sample id	CD1A CD1B CD1D P2RY6	4.63e-04	193	83	4	0e6b8e179bfe1c6e93137c76c76a91c7782a4989
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)\|Adult / Lineage, Cell type, age group and donor	FRMD4A SH2B3 P2RY6 MERTK	4.63e-04	193	83	4	31c0978ba78c9516d498aec0798902e57555e557
ToppCell	wk_15-18-Hematologic-Myeloid-Cycling_DC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CD1A CD1B CD1D P2RY6	4.63e-04	193	83	4	8e6d31546f7150ab3e8ad4fde075839e6c33842a
ToppCell	Immune-interstitial_macrophage_(C1Q_positive)\|World / Lineage, Cell type, age group and donor	FRMD4A SH2B3 P2RY6 MERTK	4.63e-04	193	83	4	64d598162a256ac6c9f8280c8a9133661dfbb10f
ToppCell	367C-Myeloid-Dendritic\|367C / Donor, Lineage, Cell class and subclass (all cells)	CD1A CD1B CD1D P2RY6	4.63e-04	193	83	4	365e831ae6ac67fb36d8d70ef139f4ae7e32c83f
ToppCell	LAM-Myeloid-DC\|Myeloid / Condition, Lineage and Cell class	CD1A CD1B P2RY6 MERTK	4.63e-04	193	83	4	f665cce40053ae5d6e28f9f70ddf78e8598c9514
ToppCell	control-Myeloid-mDC\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CD1B CD1D SH2B3 P2RY6	4.63e-04	193	83	4	5e43024763932a679c33d83cf8f606612bc0f600
ToppCell	10x5'-Lung-Myeloid_Dendritic-DC2\|Lung / Manually curated celltypes from each tissue	CD1A CD1B CD1D P2RY6	4.63e-04	193	83	4	c97f9b13057f803df63c696c6175ef8e0aba6fa7
ToppCell	Dendritic_Cells\|World / lung cells shred on cell class, cell subclass, sample id	CD1A CD1B CD1D P2RY6	4.63e-04	193	83	4	7792eb6e247af2d7a8f80476f37dcd880922d625
ToppCell	10x5'v1-week_14-16-Myeloid_DC-DC-DC2\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CD1A CD1B CD1D P2RY6	4.72e-04	194	83	4	a0cfc8c1cdc0722db39170e4417615b6e6b85041
ToppCell	cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CD1A CD1B CD1D P2RY6	4.72e-04	194	83	4	024568d8a862f0fe4da1f66a58c6e71f0e8279f3
ToppCell	343B-Myeloid-Dendritic-cDC2\|343B / Donor, Lineage, Cell class and subclass (all cells)	CD1A CD1B CD1D P2RY6	4.72e-04	194	83	4	aa6c9b71006fd3863a802d112d9c3838865a52bf
ToppCell	Control-Myeloid-MoAM4\|Myeloid / Condition, Lineage and Cell class	CD1A CD1B P2RY6 CH25H	4.72e-04	194	83	4	7ab808dd1876b0eec2831caa16d04fd859b1dc50
ToppCell	distal-2-Hematologic-Myeloid_Dendritic_Type_2\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1A CD1B CD1D SACS	4.72e-04	194	83	4	6881cfe12837a32e598535a564e4c31d4846167b
ToppCell	nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CD1A CD1B P2RY6 CSMD1	4.72e-04	194	83	4	bde6830a281f7cd7fd1733e40a41ddd2673ba88e
ToppCell	cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CD1A CD1B CD1D P2RY6	4.72e-04	194	83	4	74d588de2f84a4ef112fd642f7e112a542d5ef11
ToppCell	Bronchial_Brush-Immune-Dendritic_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	CD1D SH2B3 P2RY6 RHOF	4.72e-04	194	83	4	dbcc00940538efc0f89f074dbe822c50efa5ad8e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRMD4A SH2B3 MERTK VAV1	4.72e-04	194	83	4	c95d5c4ad0210ebd672926558cc8331e6396a854
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD1A CD1D SH2B3 P2RY6	4.72e-04	194	83	4	59180fe75be386530f1be668a37e4ada2eb19ddc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FRMD4A SH2B3 MERTK DENND4C	4.72e-04	194	83	4	45708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCell	367C-Myeloid-Dendritic-cDC2\|367C / Donor, Lineage, Cell class and subclass (all cells)	CD1A CD1B CD1D P2RY6	4.72e-04	194	83	4	d0ffba657c7308feecaa62dd54c920d32be0f129
ToppCell	343B-Myeloid-Dendritic-cDC2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CD1A CD1B P2RY6 RHOF	4.72e-04	194	83	4	ccb04f0788c98e0f63f18b09484d75ac536412a1
ToppCell	356C-Myeloid-Dendritic\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CD1A CD1B P2RY6 RHOF	4.81e-04	195	83	4	ba8b8831bd5f544f4e25f13949d04e164ecdcd12
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD1A CD1B CD1D P2RY6	4.81e-04	195	83	4	9cfbdb528088ad0ab100c7431c7d8f140a846de8
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD1A CD1B CD1D P2RY6	4.81e-04	195	83	4	7bb3bdfb8caaae357b1f7841d8d00936c4373dfe
ToppCell	Monocytes-M2-like_CD16+_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	FRMD4A P2RY6 CH25H MERTK	4.81e-04	195	83	4	10fa47bdcf6c9784ea930b75a5861e139421feed
Drug	CoA group	KAT7 PDHB NMT2 AACS IDH1 KAT6B NMT1 ACSM2A CREBBP EP300 PCSK9	4.32e-07	433	82	11	CID000000317
Drug	3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide	ARNT CREBBP EP300	4.48e-07	5	82	3	ctd:C575894
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	FRMD4A TRIB3 P2RY6 KAT6B EP300 TOE1 SMAD3	2.51e-06	168	82	7	3868_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EPM2A TRIB3 P2RY6 KAT6B CREBBP TOE1 SMAD3	2.51e-06	168	82	7	3395_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B CREBBP EP300 TOE1 SMAD3	2.82e-06	171	82	7	6879_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARNT TRIB3 KAT6B NMT1 EP300 TOE1 SMAD3	3.17e-06	174	82	7	5745_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TRIB3 P2RY6 KAT6B CREBBP EP300 TOE1 SMAD3	3.29e-06	175	82	7	1014_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B CREBBP EP300 TOE1 SMAD3	3.55e-06	177	82	7	3227_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EPM2A TRIB3 KAT6B NMT1 CREBBP TOE1 SMAD3	3.55e-06	177	82	7	3177_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A	EPM2A TNIP1 KAT6B NMT1 GMPPA VAV1 SMAD3	7.17e-06	197	82	7	1181_DN
Drug	11-ethylthioundecanoic acid	NMT2 NMT1	1.28e-05	2	82	2	CID000122099
Drug	3-methyl-2-pentanol	GRAPL GRAP	1.28e-05	2	82	2	CID000011261
Drug	AC1L1G5B	KAT7 INTU KAT6B EP300	2.27e-05	46	82	4	CID000003531
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	FRMD4A EPM2A TRIB3 P2RY6 KAT6B TOE1	2.84e-05	164	82	6	4388_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B CREBBP TOE1 SMAD3	2.94e-05	165	82	6	2835_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EPM2A TRIB3 P2RY6 KAT6B EP300 TOE1	2.94e-05	165	82	6	5625_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	TRIB3 KAT6B CREBBP EP300 TOE1 SMAD3	3.47e-05	170	82	6	1050_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	EPM2A TRIB3 KAT6B CREBBP EP300 TOE1	3.47e-05	170	82	6	3746_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B CREBBP TOE1 SMAD3	3.71e-05	172	82	6	3428_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIB3 KAT6B NMT1 CREBBP EP300 TOE1	3.71e-05	172	82	6	2794_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	FRMD4A EPM2A TRIB3 P2RY6 KAT6B SMAD3	3.71e-05	172	82	6	5903_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EPM2A TRIB3 P2RY6 KAT6B CREBBP TOE1	3.83e-05	173	82	6	3243_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B CREBBP TOE1 SMAD3	3.96e-05	174	82	6	3462_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	TRIB3 KAT6B NMT1 CREBBP EP300 SMAD3	3.96e-05	174	82	6	1659_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	TRIB3 KAT6B CREBBP EP300 TOE1 SMAD3	4.09e-05	175	82	6	1058_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B CREBBP TOE1 SMAD3	4.22e-05	176	82	6	6784_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B CREBBP TOE1 SMAD3	4.22e-05	176	82	6	1535_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EPM2A TRIB3 P2RY6 KAT6B CREBBP SMAD3	4.22e-05	176	82	6	3312_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B EP300 TOE1 SMAD3	4.35e-05	177	82	6	7550_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	TRIB3 P2RY6 KAT6B CREBBP TOE1 SMAD3	4.49e-05	178	82	6	992_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EPM2A TRIB3 P2RY6 KAT6B EP300 TOE1	4.49e-05	178	82	6	4710_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	TRIB3 KAT6B NMT1 CREBBP EP300 SMAD3	4.64e-05	179	82	6	5822_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	TRIB3 KAT6B CABIN1 CREBBP EP300 TOE1	4.64e-05	179	82	6	6609_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIB3 P2RY6 KAT6B CREBBP EP300 SMAD3	4.78e-05	180	82	6	4821_DN
Drug	Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A	CD1A ARNT PAPPA CABIN1 NMT1 TRAPPC9	7.89e-05	197	82	6	2812_UP
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A	EPM2A ARNT CABIN1 NMT1 SMAD3 EPHA5	7.89e-05	197	82	6	5939_DN
Drug	0198306-0000 [212631-61-3]; Up 200; 10uM; MCF7; HT_HG-U133A	NEURL1 KAT6B NMT1 CREBBP ARAP1 SMAD3	8.11e-05	198	82	6	7064_UP
Drug	Ascorbic acid [50-81-7]; Down 200; 22.4uM; HL60; HG-U133A	AACS CABIN1 NMT1 TRAPPC9 TOE1 ARAP1	8.57e-05	200	82	6	1610_DN
Drug	alpha-GalCer	RAG2 CD1A CD1B CD1D KAT6B	1.12e-04	131	82	5	CID002826713
Drug	NSC237521	RAG2 CD1A CD1B CD1D SH2B3 AP3B2	1.12e-04	210	82	6	CID000428410
Drug	Rifater	MERTK RHOF	1.27e-04	5	82	2	CID006474062
Drug	chloroquinone	INTU SH2B3	1.27e-04	5	82	2	CID000069671
Drug	N-myristoylGly	NMT2 NMT1	1.27e-04	5	82	2	CID000072348
Drug	anacardic acid	KAT7 KAT6B EP300	1.70e-04	30	82	3	CID000167551
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	ARNT SH2B3 IDH1 CREBBP EP300	7.25e-07	61	81	5	C1961102
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	7.44e-06	2	81	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	7.44e-06	2	81	2	cv:C4551859
Disease	Menke-Hennekam syndrome	CREBBP EP300	7.44e-06	2	81	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	7.44e-06	2	81	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	7.44e-06	2	81	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	7.44e-06	2	81	2	C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	7.44e-06	2	81	2	DOID:1933 (is_implicated_in)
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	7.44e-06	2	81	2	C0035934
Disease	Non-alcoholic Fatty Liver Disease	RAG2 TRIB3 TM6SF2 F2	4.21e-05	70	81	4	C0400966
Disease	Nonalcoholic Steatohepatitis	RAG2 TRIB3 TM6SF2 F2	4.21e-05	70	81	4	C3241937
Disease	muscular disease (implicated_via_orthology)	NMT2 NMT1	7.40e-05	5	81	2	DOID:0080000 (implicated_via_orthology)
Disease	Myocardial Infarction	SH2B3 PAPPA TM6SF2 F2	1.39e-04	95	81	4	C0027051
Disease	Adenocarcinoma of lung (disorder)	TNK1 CREBBP EP300 VAV1 EPHA5	2.63e-04	206	81	5	C0152013
Disease	Glioma	ELP1 IDH1	2.65e-04	9	81	2	cv:C0017638
Disease	glucagon-like peptide-1 measurement	CSMD1 AGBL1	3.30e-04	10	81	2	EFO_0008465
Disease	Acute Cerebrovascular Accidents	SH2B3 PRPF8 F2	4.47e-04	54	81	3	C0751956
Disease	Hematologic Neoplasms	SH2B3 IDH1	4.83e-04	12	81	2	C0376545
Disease	Thromboembolism	MERTK F2	4.83e-04	12	81	2	C0040038
Disease	serum non-albumin protein measurement	ARNT SH2B3 CH25H TNIP1 ARAP1 SMAD3	4.83e-04	361	81	6	EFO_0004568
Disease	neurofilament light chain measurement	CD1A CD1B CD1D	5.24e-04	57	81	3	EFO_0009178
Disease	rostral middle frontal gyrus volume measurement	PLA2R1 AGBL1	6.63e-04	14	81	2	EFO_0010328
Disease	Cerebrovascular accident	SH2B3 PRPF8 F2	6.71e-04	62	81	3	C0038454
Disease	hemorrhoid	FRMD4A PAPPA MERTK SMAD3	7.31e-04	147	81	4	EFO_0009552
Disease	myelodysplastic syndrome (implicated_via_orthology)	PRPF8 CREBBP	7.64e-04	15	81	2	DOID:0050908 (implicated_via_orthology)
Disease	Coronary Arteriosclerosis	SH2B3 PAPPA PCSK9	7.70e-04	65	81	3	C0010054
Disease	Coronary Artery Disease	SH2B3 PAPPA PCSK9	7.70e-04	65	81	3	C1956346
Disease	Familial Progressive Myoclonic Epilepsy	EPM2A SACS	9.85e-04	17	81	2	C0751777
Disease	Atypical Inclusion-Body Disease	EPM2A SACS	9.85e-04	17	81	2	C0751776
Disease	Myoclonic Epilepsies, Progressive	EPM2A SACS	9.85e-04	17	81	2	C0751778
Disease	Biotin-Responsive Encephalopathy	EPM2A SACS	9.85e-04	17	81	2	C0751780
Disease	May-White Syndrome	EPM2A SACS	9.85e-04	17	81	2	C0751782
Disease	Dentatorubral-Pallidoluysian Atrophy	EPM2A SACS	9.85e-04	17	81	2	C0751781
Disease	Action Myoclonus-Renal Failure Syndrome	EPM2A SACS	1.11e-03	18	81	2	C0751779
Disease	diffuse plaque measurement	FRMD4A PLA2R1 TTLL11 CH25H TNIP1 FAM124A KAT6B ACSM2A	1.13e-03	758	81	8	EFO_0010699
Disease	glomerulonephritis (is_marker_for)	F2 EP300	1.23e-03	19	81	2	DOID:2921 (is_marker_for)
Disease	hemifacial microsomia	FRMD4A NMT1	1.23e-03	19	81	2	MONDO_0015398
Disease	autoimmune disease	SH2B3 TNIP1 NEURL4 RAVER1	1.34e-03	173	81	4	EFO_0005140
Disease	Leukemia, Myelocytic, Acute	SH2B3 IDH1 CREBBP EP300	1.34e-03	173	81	4	C0023467
Disease	proprotein convertase subtilisin/kexin type 9 measurement	TM6SF2 PCSK9	1.66e-03	22	81	2	EFO_0009312
Disease	HMG CoA reductase inhibitor use measurement	TM6SF2 DENND4C SMAD3 PCSK9	1.85e-03	189	81	4	EFO_0009932
Disease	ankylosing spondylitis	SH2B3 MYOM2 CSMD1	2.03e-03	91	81	3	EFO_0003898
Disease	alpha-linolenic acid measurement	CSMD1 LCT	2.14e-03	25	81	2	EFO_0007759
Disease	level of Sterol ester (27:1/16:0) in blood serum	TM6SF2 PCSK9	2.32e-03	26	81	2	OBA_2045191
Disease	cholesterol to total lipids in small LDL percentage	TM6SF2 PCSK9	2.50e-03	27	81	2	EFO_0022241
Disease	lumbar disc degeneration	CSMD1 SMAD3	2.69e-03	28	81	2	EFO_0004994

Protein segments in the cluster

Peptide	Gene	Start	Entry
RPLAQPACLTFWYHG	MAMDC4	881	Q6UXC1
VHCTGYIKAWPPAGV	ARNT	306	P27540
KKLGYTTGHIWACPP	EP300	1426	Q09472
DCIWLITVPPGHGVY	CSMD1	2171	Q96PZ7
PGIWAHGDYCRINPK	AACS	516	Q86V21
CARAKRPGIYTATWP	ACR	266	P10323
IRCHWTIRLPPGYQV	CDCP2	281	Q5VXM1
PWALGACTFVHLLPK	ACSM2A	276	Q08AH3
AVAHPSLIWRCGYSK	EPHA5	611	P54756
KPHPWYSGRISRQLA	GRAPL	56	Q8TC17
KPHPWYSGRISRQLA	GRAP	56	Q13588
KGDVSLCRWHPKPYC	FBXO34	641	Q9NWN3
VKKLGYVTGHIWACP	CREBBP	1461	Q92793
GHYPWSCPVTHTREK	BIVM	51	Q86UB2
QLVCHVSGFYPKPVW	CD1B	221	P29016
WYGPAVVAHILRKAV	ATG4C	231	Q96DT6
LGKPTWIRTGHEICY	AGBL1	676	Q96MI9
WLIGEYCEHVPRIAP	AP3B2	506	Q13367
WPKRSCPTGVFHLDV	RAG2	36	P55895
KPLGPRTLYVHWTDA	RAVER1	196	Q8IY67
APVGKIHPYISWRLQ	IQCJ	101	Q1A5X6
CGWFHPPANEIYRRK	KAT6B	771	Q8WYB5
WYHLCLPEGRALPVF	FCN3	106	O75636
YGHCPGLKVVSPWNS	PDHB	166	P11177
PPKHWRYGEAACRLE	P2RY11	91	Q96G91
HYSRILPNIWLGSCP	EPM2A	156	O95278
AKCVWKHPPGDEIYR	KAT7	386	O95251
VLPKPVGTCRYWHRS	NMT1	286	P30419
GVVLPKPIATCRYWH	NMT2	286	O60551
VKIFIPAHGWVDYAP	MERTK	476	Q12866
CALGRVPWRKFPVHV	AQP7B	106	A0A075B734
LVCHVSGFYPKPVWV	CD1A	221	P06126
GTPLWAIRPVHYGKE	FAM124A	156	Q86V42
RCAKDPWRLPGTYVV	PCSK9	66	Q8NBP7
PRAYKRWVCSLPFGH	EFNA4	91	P52798
PGWAPYRIAHAVIKA	LCT	1086	P09848
WDPVTPYRLHVLCQG	ELP1	351	O95163
RVVCTAGLKWYPHPA	PAPPA	1536	Q13219
GRWVHIVCALYVPGV	PHF14	401	O94880
SPLRAREYVWAPGHC	ADAMTSL5	411	Q6ZMM2
HWLIRGPLEYVPSAK	MVP	356	Q14764
AYWVVGRLFLHPKPQ	INTU	901	Q9ULD6
FQIPPWHLDRKYGSC	CCNYL3	6	P0C7X3
GIAVHTWYACPALIK	FRMD4A	291	Q9P2Q2
PWIRGNVYIHPTAKV	GMPPA	281	Q96IJ6
VSGWVKPIIIGRHAY	IDH1	121	O75874
CIIKPHYPAWVPVSV	IGSF3	566	O75054
GPIWKHATPVLNCFR	CABIN1	1116	Q9Y6J0
LLVCHVSGFYPKPVW	CD1D	221	P15813
HVAAGWSPDPKYQIC	DUSP15	206	Q9H1R2
PRKRYVYVWHCPQGP	FOXRED1	321	Q96CU9
LWFICLPAYVRVSHP	DENND4C	781	Q5VZ89
VWGLATHPYLPICAT	EML5	1001	Q05BV3
YCHGWRPAGQRVPSK	H1-9P	86	P60008
WTVKPHIGEVFCYLP	SACS	1861	Q9NZJ4
GWCKSYRPVSVAVIH	PROCA1	146	Q8NCQ7
LCSWVPALRRYKIHP	CH25H	61	O95992
PPRVWAVVDLYGKCT	NEURL4	186	Q96JN8
SFQRYLGICHPLAPW	P2RY6	121	Q15077
IKWFPEVTHFCRGIP	RHOF	111	Q9HBH0
SDYLPCAGVLIHPLW	PRSS58	36	Q8IYP2
TPKQHGTCPKGWLYF	PLA2R1	951	Q13018
KLRPPTCWGFTVVHE	ARAP1	1351	Q96P48
APFLCHPNLWIRYGA	PIK3R4	661	Q99570
LVKNWYREHCPAGQP	PRPF8	426	Q6P2Q9
FHLPEYTWRLPCGGV	TNIP1	591	Q15025
PFGRRLPCDIYWHGV	TTLL11	246	Q8NHH1
KEFWAVCRVPGPLHS	NEURL1	381	O76050
RYSDAWRVHQPGCKP	MEX3A	316	A1L020
NQRYGWHPATVCKIP	SMAD3	321	P84022
LWDKHACPAYVGPEI	TRIB3	216	Q96RU7
EIGWFPCNRVKPYVH	VAV1	646	P15498
CYPWFHGPISRVKAA	SH2B3	361	Q9UQQ2
ALYSLALRCWAPHPA	TNK1	351	Q13470
GIECQLWRSRYPHKP	F2	126	P00734
KRPEFVRGYNHPCGW	STARD4	141	Q96DR4
VAPSIAEPGWRACYK	TRAPPC9	416	Q96Q05
GPHLLAYRCLQWPAF	TM6SF2	346	Q9BZW4
EIIPCRIHLVWYPGK	RARRES1	246	P49788
WGCLYPIPREHLISL	ZFYVE26	1566	Q68DK2
IRHGLWICPFGKTSP	TMEM267	161	Q0VDI3
GPWLPECHNKVYLSG	TOE1	466	Q96GM8
HWVYVKRGGNCPAPT	ZBTB22	296	O15209
WEPCNHKPIGYNRFV	MYOM2	656	P54296